Covid-19 Impact on Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2020-2026
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry.
Based on our recent survey, we have several different scenarios about the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry.
Based on our recent survey, we have several different scenarios about the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market.
The following players are covered in this report:
- Roche (Genentech)
- Amgen
- B-MS
- Merck
- Pfizer
- Novartis
- Eli Lilly and Company
- Johnson & Johnson
- GSK
- Sanofi
- Boehringer Ingelheim
- Zhejiang Jiuzhou Pharmaceutical
- Aspirin
- Ibuprofen
- Naproxen
- Celecoxib
- Others
- Drug Store
- Hospital Pharmacies
- Online
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Celecoxib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Hospital Pharmacies
1.5.4 Online
1.6 Coronavirus Disease 2019 (Covid-19): Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Impact
1.6.1 How the Covid-19 is Affecting the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry
1.6.1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.4 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.5 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)
5 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
8 CHINA
8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
8.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
9.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
9.4 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
11 INDIA
11.1 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
11.3 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
11.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
12.4 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche (Genentech)
13.1.1 Roche (Genentech) Company Details
13.1.2 Roche (Genentech) Business Overview and Its Total Revenue
13.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
13.1.5 Roche (Genentech) Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 B-MS
13.3.1 B-MS Company Details
13.3.2 B-MS Business Overview and Its Total Revenue
13.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.3.5 B-MS Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Details
13.7.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.7.5 Eli Lilly and Company Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
13.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 GSK
13.9.1 GSK Company Details
13.9.2 GSK Business Overview and Its Total Revenue
13.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.9.5 GSK Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview and Its Total Revenue
13.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Details
10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.11.5 Boehringer Ingelheim Recent Development
13.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview and Its Total Revenue
10.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Celecoxib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Hospital Pharmacies
1.5.4 Online
1.6 Coronavirus Disease 2019 (Covid-19): Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Impact
1.6.1 How the Covid-19 is Affecting the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry
1.6.1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.4 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.5 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)
5 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
8 CHINA
8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
8.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
9.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
9.4 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
11 INDIA
11.1 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
11.3 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
11.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
12.4 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche (Genentech)
13.1.1 Roche (Genentech) Company Details
13.1.2 Roche (Genentech) Business Overview and Its Total Revenue
13.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
13.1.5 Roche (Genentech) Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 B-MS
13.3.1 B-MS Company Details
13.3.2 B-MS Business Overview and Its Total Revenue
13.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.3.5 B-MS Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Details
13.7.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.7.5 Eli Lilly and Company Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
13.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 GSK
13.9.1 GSK Company Details
13.9.2 GSK Business Overview and Its Total Revenue
13.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.9.5 GSK Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview and Its Total Revenue
13.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Details
10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.11.5 Boehringer Ingelheim Recent Development
13.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview and Its Total Revenue
10.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
Table 3. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aspirin
Table 6. Key Players of Ibuprofen
Table 7. Key Players of Naproxen
Table 8. Key Players of Celecoxib
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players to Combat Covid-19 Impact
Table 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2015-2020)
Table 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
Table 25. Main Points Interviewed from Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2015-2020) (Million US$)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2015-2020)
Table 28. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 32. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 35. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2015-2020)
Table 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026)
Table 37. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2015-2020)
Table 38. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 39. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2021-2026)
Table 40. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 42. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 43. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 44. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 45. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 46. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 48. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 50. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 52. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 53. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 54. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 55. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 56. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 57. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 58. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 60. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 62. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 66. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 68. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 70. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 71. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 72. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 73. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 74. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 75. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 78. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 80. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 82. Roche (Genentech) Company Details
Table 83. Roche (Genentech) Business Overview
Table 84. Roche (Genentech) Product
Table 85. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 86. Roche (Genentech) Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Product
Table 90. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 91. Amgen Recent Development
Table 92. B-MS Company Details
Table 93. B-MS Business Overview
Table 94. B-MS Product
Table 95. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 96. B-MS Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Product
Table 100. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 101. Merck Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Product
Table 110. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 111. Novartis Recent Development
Table 112. Eli Lilly and Company Company Details
Table 113. Eli Lilly and Company Business Overview
Table 114. Eli Lilly and Company Product
Table 115. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 116. Eli Lilly and Company Recent Development
Table 117. Johnson & Johnson Business Overview
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Company Details
Table 120. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 121. Johnson & Johnson Recent Development
Table 122. GSK Company Details
Table 123. GSK Business Overview
Table 124. GSK Product
Table 125. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 126. GSK Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi Product
Table 130. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 131. Sanofi Recent Development
Table 132. Boehringer Ingelheim Company Details
Table 133. Boehringer Ingelheim Business Overview
Table 134. Boehringer Ingelheim Product
Table 135. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 136. Boehringer Ingelheim Recent Development
Table 137. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 138. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 139. Zhejiang Jiuzhou Pharmaceutical Product
Table 140. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 141. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
Table 3. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aspirin
Table 6. Key Players of Ibuprofen
Table 7. Key Players of Naproxen
Table 8. Key Players of Celecoxib
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players to Combat Covid-19 Impact
Table 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2015-2020)
Table 19. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
Table 25. Main Points Interviewed from Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2015-2020) (Million US$)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2015-2020)
Table 28. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 32. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 35. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2015-2020)
Table 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026)
Table 37. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2015-2020)
Table 38. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 39. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2021-2026)
Table 40. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 42. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 43. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 44. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 45. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 46. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 48. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 50. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 52. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 53. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 54. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 55. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 56. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 57. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 58. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 60. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 62. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 66. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 68. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 70. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 71. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 72. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 73. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 74. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 75. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 78. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 80. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 82. Roche (Genentech) Company Details
Table 83. Roche (Genentech) Business Overview
Table 84. Roche (Genentech) Product
Table 85. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 86. Roche (Genentech) Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Product
Table 90. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 91. Amgen Recent Development
Table 92. B-MS Company Details
Table 93. B-MS Business Overview
Table 94. B-MS Product
Table 95. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 96. B-MS Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Product
Table 100. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 101. Merck Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Product
Table 110. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 111. Novartis Recent Development
Table 112. Eli Lilly and Company Company Details
Table 113. Eli Lilly and Company Business Overview
Table 114. Eli Lilly and Company Product
Table 115. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 116. Eli Lilly and Company Recent Development
Table 117. Johnson & Johnson Business Overview
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Company Details
Table 120. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 121. Johnson & Johnson Recent Development
Table 122. GSK Company Details
Table 123. GSK Business Overview
Table 124. GSK Product
Table 125. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 126. GSK Recent Development
Table 127. Sanofi Company Details
Table 128. Sanofi Business Overview
Table 129. Sanofi Product
Table 130. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 131. Sanofi Recent Development
Table 132. Boehringer Ingelheim Company Details
Table 133. Boehringer Ingelheim Business Overview
Table 134. Boehringer Ingelheim Product
Table 135. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 136. Boehringer Ingelheim Recent Development
Table 137. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 138. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 139. Zhejiang Jiuzhou Pharmaceutical Product
Table 140. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 141. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2026
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2026
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2019
Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
Figure 19. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Roche (Genentech) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 30. B-MS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 38. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 42. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 44. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 46. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 48. Zhejiang Jiuzhou Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2026
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2026
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2019
Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
Figure 19. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Roche (Genentech) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 30. B-MS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 38. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 42. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 44. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 46. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 48. Zhejiang Jiuzhou Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
